Author: viveksharma

Emcure Pharmaceuticals Ltd. was incorporated in the year 1981. Its today's share price is 0. Its current market capitalisation stands at Rs 0 Cr. In the latest quarter, company has... Read More

Emcure Pharmaceuticals on Thursday said it has filed draft papers with Sebi for initial public offer (IPO). Sources said the size of the offer could be in the range of... Read More

Emcure Pharmaceuticals Limited is an unlisted public company incorporated on 16 April, 1981. It is classified as a public limited company and is located in Pune, Maharashtra. It's authorized share... Read More

PUBLIC ISSUE OF [●] EQUITY SHARES OF FACE VALUE ` 10 EACH (THE “EQUITY SHARES”) OF EMCURE PHARMACEUTICALS LIMITED (THE “COMPANY” OR THE “ISSUER”) FOR CASH AT A PRICE OF `... Read More

Emcure Pharmaceuticals, one of the fastest-growing drug makers by sales in the domestic market, is planning to strengthen its product portfolio with new launches, line extensions of existing brands... Read More

Pune-based Emcure Pharmaceuticals Ltd, (Emcure) has entered into a collaboration with Swiss pharma major Roche for local manufacturing and marketing of Roche innovative molecules in India, under its supervision and... Read More

Satish Mehta, MD & CEO, Emcure Pharma is currently having a moment under the sun. Emcure’s subsidiary, Gennova, is developing India’s first indigenously developed mRNA COVID-19 vaccine that is currently... Read More

Emcure Pharmaceuticals Ltd is seeing new growth opportunities in biologics and vaccines which it intends to introduce in various emerging markets. Being the first Indian company to have developed an... Read More

Emcure Pharmaceuticals on Thursday said it has filed draft papers with Sebi for initial public offer (IPO). Sources said the size of the offer could be in the range of... Read More

Pune-based Emcure Pharmaceuticals has come forth again to publicly list its shares on exchanges. In 2014, the company had attempted to hit the stock exchanges, but reportedly did not pursue it... Read More